Skip to main content
ADDvise Group B logo

ADDvise Group B — Investor Relations & Filings

Ticker · ADDV ISIN · SE0001306119 LEI · 549300C17TZXE1IEOA66 ST Wholesale and retail trade
Filings indexed 399 across all filing types
Latest filing 2024-01-04 Regulatory Filings
Country SE Sweden
Listing ST ADDV

About ADDvise Group B

https://www.addvisegroup.com/

ADDvise Group is an international life science company that provides comprehensive solutions, including products and services, to the healthcare and research sectors. The group operates through two primary business areas: Lab and Healthcare. The Lab division supplies laboratory equipment, furnishings, and consumables to public and private research facilities. The Healthcare division offers medical devices and equipment to various healthcare providers. ADDvise Group expands through the acquisition and development of high-quality companies, utilizing a decentralized ownership model that allows its subsidiaries to operate with autonomy while benefiting from corporate support.

Recent filings

Filing Released Lang Actions
ADDvise receives order worth USD 2.5 million
Regulatory Filings Classification · 95% confidence The document is a short press release announcing a new business order worth USD 2.5 million for a subsidiary. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate announcement regarding business operations and contract wins, it falls under the fallback category for regulatory announcements.
2024-01-04 English
ADDvise erhåller order till ett värde av 3 MUSD
Regulatory Filings Classification · 95% confidence The document is a press release announcing a new business order worth 3 MUSD for a subsidiary of ADDvise Group AB. It provides details about the contract, the client, and the expected delivery timeline. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate announcement regarding business operations, it falls under the regulatory filing category.
2023-12-29 Swedish
ADDvise receives order worth USD 3 million
Regulatory Filings Classification · 95% confidence The document is a short press release announcing a new commercial order worth USD 3 million for ADDvise Group AB. It does not fit into specific categories like financial reports, M&A, or director dealings. As it is a general corporate announcement regarding business operations disclosed under the EU Market Abuse Regulation, it falls under the fallback category for regulatory announcements.
2023-12-29 English
ADDvise acquires Labplan Ltd.
M&A Activity Classification · 100% confidence The document is a press release announcing the acquisition of Labplan Ltd. by ADDvise Group. It details the share purchase agreement, financial metrics of the acquired company, the purchase price, and the financing method. This falls squarely under M&A activity (mergers and acquisitions).
2023-12-22 English
ADDvise förvärvar Labplan Ltd.
M&A Activity Classification · 100% confidence The document is an official announcement regarding ADDvise Group's acquisition of Labplan Ltd. It details the terms of the acquisition, financial metrics of the target company, and the strategic rationale. This falls directly under the definition of M&A activity (takeover/acquisition announcement).
2023-12-22 Swedish
ADDvise beslutar att inte fullfölja förvärvet av Innovative Endoscopy Components, LLC.
M&A Activity Classification · 100% confidence The document is a press release announcing the termination of a previously announced acquisition (Innovative Endoscopy Components, LLC). Since the document specifically details the cancellation of an M&A transaction, it falls under the category of M&A Activity (TAR).
2023-12-22 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.